Description

Semaglutide injection 2 mg/3 mL (0.68 mg/mL) pre-filled pen is a semaglutide injection formulation used under medical supervision. Semaglutide belongs to the GLP-1 receptor agonist class and is used in appropriate patients as part of a broader treatment plan. For buyers in India, recent regulatory information is particularly relevant. The Central Drugs Standard Control Organisation (CDSCO) records a semaglutide injection 2 mg/3 mL with a 0.68 mg/mL concentration in a pre-filled pen, with an approval dated July 1, 2026. The listed indication is treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise, including specified situations involving other diabetes medicines. What Is Semaglutide Injection 2 mg/3 mL Used For? The Semaglutide injection 2 mg/3 mL (0.68 mg/mL) pre-filled pen contains semaglutide, which acts on GLP-1 receptors involved in glucose regulation and appetite-related processes. The specific formulation recorded by CDSCO is indicated for eligible adults with insufficiently controlled type 2 diabetes, alongside diet and exercise. Importantly, 2 mg/3 mL describes the total amount and volume of the formulation; it should not automatically be interpreted as a 2 mg dose per injection. The dose delivered depends on the particular pen and the prescription. Patients should follow the product instructions and their healthcare professional's directions rather than calculating doses independently. Key Benefits of Semaglutide When appropriately prescribed, potential benefits include: Improved blood-glucose control: Semaglutide can help eligible adults with type 2 diabetes achieve better glycemic control as part of an overall treatment plan. GLP-1-based action: The medicine works through GLP-1 receptors involved in blood-glucose regulation and appetite. Convenient pre-filled pen: A pre-filled injection device can simplify medication administration when used according to the manufacturer's instructions. Part of comprehensive diabetes care: Semaglutide is intended to complement appropriate diet, exercise and other prescribed diabetes treatments rather than replace them. Common Semaglutide Side Effects Semaglutide may cause gastrointestinal side effects, particularly during treatment initiation or dose changes. Commonly reported effects can include nausea, vomiting, diarrhea, constipation, abdominal discomfort and reduced appetite. Patients should seek medical advice if side effects are severe, persistent or concerning. Serious adverse reactions are possible with semaglutide, so the medicine should be used only after an appropriate medical assessment. Buying Semaglutide 2 mg/3 mL Online: What Should You Check? If your search intent is “buy semaglutide injection 2 mg/3 mL online,” safety and authenticity should come before price. Before purchasing, verify: The product is exactly 2 mg/3 mL (0.68 mg/mL). It is supplied as the prescribed pre-filled pen. The manufacturer and batch information are clearly displayed. The seller is an appropriately licensed pharmacy. Packaging is sealed and authentic. Storage and handling requirements have been maintained. The product matches your prescription and intended indication. This is especially important because CDSCO's July 2026 records show multiple semaglutide concentrations and presentations, including 2 mg/3 mL, 4 mg/3 mL and 8 mg/3 mL pre-filled pen formulations. Conclusion Semaglutide injection 2 mg/3 mL (0.68 mg/mL) pre-filled pen is a specific semaglutide formulation that, according to recent CDSCO information, is approved in India for appropriate adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise. Its potential advantages include glucose-control support and convenient pre-filled-pen administration. However, side effects—particularly gastrointestinal symptoms—can occur, and treatment should be individualized by a healthcare professional. Buyers should verify the exact concentration, manufacturer, authenticity, prescription requirements and storage conditions before purchasing. Frequently Asked Questions 1. What is semaglutide injection 2 mg/3 mL (0.68 mg/mL) used for? It is a semaglutide GLP-1 receptor agonist formulation indicated in the recent CDSCO record for eligible adults with insufficiently controlled type 2 diabetes, alongside diet and exercise. 2. Is 2 mg/3 mL the same as a 2 mg injection? Not necessarily. The label describes the total semaglutide content and volume. The actual dose administered depends on the pen's dosing system and the prescription. 3. What are the main benefits of semaglutide? Potential benefits include improved blood-glucose control in appropriate patients and convenient administration using a pre-filled pen. 4. What are the common side effects of semaglutide? Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal discomfort and reduced appetite.